8-K
XBRL
CURRENT REPORT
- Company
- Unicycive Therapeutics, Inc.
- Filed
- December 29, 2022
- Period of Report
- December 29, 2022
- Accession Number
- 0001213900-22-083446
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →